公开(公告)号：US20210267251A1

公开(公告)日：2021-09-02

申请号：US17254403

申请日：2019-05-24

申请人： SOCIETE DES PRODUITS NESTLE S.A.

发明人： Bernard Cuenoud ,  India C. Severin

IPC分类号： A23L33/00 ,  A23L33/125 ,  A61K31/121 ,  A61K31/455

摘要： A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD+) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.

公开(公告)号：US20210121488A1

公开(公告)日：2021-04-29

申请号：US17254417

申请日：2019-05-24

申请人： SOCIETE DES PRODUITS NESTLE S.A.

发明人： Bernard Cuenoud ,  India C. Severin ,  Pascal Steiner

IPC分类号： A61K31/706 ,  A61K31/19 ,  A61K31/121 ,  A61K9/00 ,  A23L33/00 ,  A23L33/125

摘要： A composition can treat or prevent at least one physical state selected from the group consisting of oxidative stress, a condition associated with oxidative stress, a reduced level of glutathione, and a condition associated with a reduced level of glutathione, in particular neurodegenerative disease, depression, anxiety, decreased/low motivation, impaired cognitive function, mild cognitive impairment. The composition contains an effective amount of a combination of a Nicotinamide Adenine Dinucleotide (NAD+) precursor and at least one ketone or ketone precursor. The composition can be an enterally administered composition such as an orally administered food product or food supplement.